Back to results
CompletedPhase 3

An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives

NCT04476446

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Clínica de Ansiedad, Depresión y Estrés CADE, S. de R.L. de C.V.

Guadalajara, Mexico

+7 additional locations

View on ClinicalTrials.gov
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives — TrialFind